News

All Categories

28 September 2015

OpenLearning and Smart Sparrow in edtech partnership

The Australian Financial Review

14 September 2015

Hatchtech inks $279m head lice deal as VC market comes to life

Sydney Morning Herald

30 July 2015

Emerging Systems to integrate Charm into EHS

20 July 2015

Start-ups must take risk and look outward: VC fund

12 June 2015

Super funds opt-in clause could boost innovation

12 June 2015

Venture capitalists target super fund members and SMSFs

Sydney Morning Herald

11 June 2015

Charm Health signs master agreement with Healthscope

29 May 2015

Invetech and Vaxxas named recipients of the 2015 Good Design Award for Development of Nanopatch Jet Coating Instrument for Needle-Free Drug Delivery

07 May 2015

OneVentures appoints new Venture Partner

26 March 2015

Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

23 February 2015

Vaxxas Nanopatch on Channel 7 News and Today Tonight

11 February 2015

Investors keen on biotech injection: OneVentures

10 February 2015

Nanopatch vaccine technology company attracts $25 million

10 February 2015

A company developing needle-free vaccination tech just raised $25 million

10 February 2015

Vaxxas raises $25m in Series B financing

10 February 2015

Painful needles could one day be a thing of the past as Queensland’s Nanopatch gets financial injection

20 December 2014

Old world money unites with best and brightest in world of disruption

01 December 2014

The Adaptive advantage: how e-learning will change higher ed

17 November 2014

Replacing vaccine needles with tens of thousands of drug-laced pins that won’t hurt a bit

07 November 2014

NICTA start-up Incoming Media backed with US$4.9M Series A funding

04 November 2014

Incoming Media Receives Investment from OneVentures and Intel Capital

27 October 2014

Singapore ahead in help for start-ups

The Australian Financial Review

23 October 2014

OneVentures ready to invest in start-ups as it builds $100m fund

The Australian Financial Review

21 October 2014

Hatchtech announces successful results from Phase 2 ovicidal study

decor decor decor
decor decor decor decor decor